| Medical and Health Sciences | Lifetime | 604 | FR 9 | 99.97 |
| Pulmonary and Respiratory Medicine | Lifetime | 35 | FR 4 | 99.96 |
| Rheumatology | Lifetime | 138 | FR 6 | 99.44 |
| Pathology and Forensic Medicine | Lifetime | 468 | FR 17 | 98.02 |
| Medical Genetics | Lifetime | 454 | FR 21 | 95.84 |
| Nephrology | Lifetime | 701 | FR 22 | 90.42 |
| Hepatology | Lifetime | 916 | FR 53 | 76.92 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 553 | FR 34 | 93.77 |
| Rheumatology | 2021-2025 | 481 | FR 22 | 73.18 |
| Vasculitis and related conditions | Lifetime | 2 | FR 1 | 99.95 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 2 | FR 1 | 99.88 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 2 | FR 1 | 99.91 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 12 | FR 1 | 99.65 |
| Eosinophilic Disorders and Syndromes | Lifetime | 17 | FR 1 | 99.75 |
| Renal Diseases and Glomerulopathies | Lifetime | 26 | FR 3 | 99.68 |
| Systemic Sclerosis and Related Diseases | Lifetime | 32 | FR 5 | 99.59 |
| Urticaria and Related Conditions | Lifetime | 29 | FR 1 | 99.48 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 33 | FR 1 | 99.30 |
| Systemic Lupus Erythematosus Research | Lifetime | 132 | FR 8 | 99.45 |
| Kawasaki Disease and Coronary Complications | Lifetime | 58 | FR 4 | 98.19 |
| Autoimmune and Inflammatory Disorders | Lifetime | 84 | FR 6 | 98.48 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 309 | FR 23 | 98.22 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 559 | FR 38 | 97.42 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 147 | FR 9 | 96.64 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 607 | FR 20 | 96.37 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 258 | FR 24 | 96.41 |
| Peripheral Neuropathies and Disorders | Lifetime | 443 | FR 26 | 96.63 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 191 | FR 5 | 93.87 |
| Mast cells and histamine | Lifetime | 747 | FR 45 | 93.98 |
| Complement system in diseases | Lifetime | 983 | FR 64 | 93.04 |
| Skin Diseases and Diabetes | Lifetime | 332 | FR 26 | 90.97 |
| Vascular Anomalies and Treatments | Lifetime | 383 | FR 42 | 91.68 |
| Abdominal vascular conditions and treatments | Lifetime | 873 | FR 56 | 87.94 |
| Connective Tissue Growth Factor Research | Lifetime | 616 | FR 31 | 77.81 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 764 | FR 20 | 54.12 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 309 | FR 28 | 51.97 |
| Vasculitis and related conditions | 2021-2025 | 78 | FR 8 | 97.09 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 166 | FR 12 | 91.72 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 297 | FR 23 | 88.56 |
| Urticaria and Related Conditions | 2021-2025 | 539 | FR 23 | 83.18 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 777 | FR 54 | 76.84 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 414 | FR 80 | 69.33 |
